NANicola Antonacci

Nicola Antonacci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicola Antonacci has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Systematic review of laparoscopic versus open surgery in the treatment of non-parasitic liver cysts

    by Nicola Antonacci, Claudio Ricci, Giovanni Taffurelli, Riccardo Casadei, Francesco Minni

    We conducted a systematic review of the literature on the electronic databases Medline, Embase, Ovid and Cochrane to identify studies from 1990 to 2011 regarding the surgical management of non-parasitic liver cysts treated with laparoscopy (LT) and/or laparotomy (OT) to identify short-term and long-term outcomes of the relative treatments. Two reviewers independently extracted data regarding the following parameters: first author, year of publication, type of journal, study design, number of patients operated on, male/female ratio, mean age, mean size of the cysts treated, laparoscopic conversion rate, morbidity, mortality and recurrence in both groups (LT and OT). A qualitative analysis was carried out using the Pearson Chi square test and the Fischer’s exact test where necessary. The data analysis was conducted by dividing the sample into three periods in relation to the development of laparoscopic surgery: period 1 (P1), 1990–1995 “pioneering” period of laparoscopy; period 2 (P2), 1996–2000 period of the “development of laparoscopy”; period 3 (P3), 2001–2011 period of “diffusion of laparoscopy.” Thirty studies involving 948 patients comparing LT with OT were included in the final pooled analysis. Twenty-two studies were retrospective (73.3 %) and only 8 (26.7 %) were prospective. The number of publications increased during the three periods analysed. The correlation between the type of journal and the year of publication showed an increase (p = 0.048) in journals dedicated to LT during the three periods. In P1, the preferred approach was open surgery (66.3 %) with only 11 cases treated with LT. The conversion rate was 18.1 %. The overall complication rate was 33.3 % with a substantial equivalence between the two approaches (27.2 % for laparoscopic surgery and 36.6 % for laparotomic). The overall recurrence rate was 18.1 % with 36.3 % in the laparoscopic group and 9.2 % in the laparotomic group. In P2, the preferred approach was laparoscopic (56.7 %). The conversion rate was 2.3 %. The overall complication rate was 5.8 % but with some differences between the two approaches (10.3 % for the laparoscopic approach and 0 % for open surgery). The overall recurrence rate was 14.4 % with 17.4 % in the laparoscopic group and 10.4 % in the laparotomic group. In P3, the preferred approach was laparoscopic (69.9 %). The overall recurrence rate was 11.1 %; it was 6.1 % for the laparoscopic approach while it was 11.5 % for laparotomic. In all three periods analysed, the laparoscopic approach showed a statistically significant reduction in operative time (p = 0.009) and hospital stay (p = 0.001) and a significant (p < 0.05) reduction rate in symptomatic recurrences in patients with polycystic liver disease (25 %) as compared with simple liver cysts (7.5 %). The current data in the literature show that the laparoscopic approach may be the treatment of choice in patients with symptomatic non-parasitic cysts of the liver, providing the short-term advantages of minimally invasive surgery. Recurrence rates were acceptable and comparable to those of conventional surgery. Long-term outcomes should be verified by additional randomised controlled trials and long-term follow-ups.


  • Open Access

    Asymptomatic Cholecystocolonic Fistula: A Diagnostic and Therapeutic Dilemma

    by Nicola Antonacci, Giovanni Taffurelli, Riccardo Casadei, Claudio Ricci, Francesco Monari, Francesco Minni

    Cholecystocolonic fistulas (CCF) are rare complications of gallstones with a variable clinical presentation. Despite modern diagnostic tools, cholecystocolonic fistulas are often asymptomatic and it is difficult to diagnose them preoperatively. Biliary-enteric fistulae have been found in 0.9% of patients undergoing biliary tract surgery. The most common site of communication of the fistula is the cholecystoduodenal (70%), followed by the cholecystocolic (10–20%), and the least common is the cholecystogastric fistula. Herein, we report a case of female patient with multiple episodes of acute recurrent cholangitis due to common bile duct and gallbladder stones in which preoperative imaging studies were negative for cholecystocolonic fistula that was incidentally discovered and treated during surgery and was appropriately treated. A review of the literature is reported too.


  • Open Access

    A bizarre foreign body in the appendix: A case report

    by Nicola Antonacci, Marcello Labombarda, Claudio Ricci, Salvatore Buscemi, Riccardo Casadei, Francesco Minni

    A bizarre foreign body in the appendix: A case report


  • Diverticulum of the midthoracic oesophagus and left diaphragmatic relaxation

    by Nicola Antonacci, Gianluca Sciannamea, Filippo Antonacci, Riccardo Casadei, Claudio Ricci, Salomone Di Saverio, Francesco Minni

    The case of a 58-year-old man with a large midthoracic oesophageal diverticulum and a left diaphragmatic relaxation who presented with night regurgitations, abdominal bloating, epigastric burning and a sensation of fullness after meals is reported. The patient underwent a successful thoracotomic diverticulectomy with left diaphragmatic plicature. The postoperative course was uneventful. To our knowledge this is the first reported case of an association between midthoracic oesophageal diverticulum and left diaphragmatic relaxation. Moreover, we hypothesised that the diverticulum was caused by a pulsion mechanism due to obstruction of the distal oesophagus secondary to diaphragmatic relaxation.


  • Une tumeur stromale (GIST) gastrique exophytique révélée par un abdomen aigu: une présentation extrêmement rare. À propos d’un cas

    by M. Casali, N. Antonacci, S. Di Saverio, A. Cancellieri, C. Calandri, A. Biscardi, G. Tugnoli, M. Giovannini, F. Baldoni

    Les tumeurs stromales gastro-intestinales (GIST) sont les néoplasies mésenchymateuses les plus fréquentes du tube digestif. L’atteinte gastrique est la plus courante (60–70 %), suivie de celle de l’intestin grêle (20–30 %). Les GIST possèdent des caractéristiques immunohistochimiques spécifiques, essentielles au diagnostic. Près de 95%des GIST expriment le c-kit (antigène CD117), un récepteur transmembranaire tyrosine-kinase dont l’activation déclenche la prolifération cellulaire. La chirurgie est le traitement de choix des tumeurs résécables, alors que le traitement standard des tumeurs non résécables est l’administration d’imatinib (Glivec®), un inhibiteur compétitif de c-kit/PDGFRA. Le taux de réponse au traitement par imatinib est d’environ 80 %. Le diagnostic des GIST peut être accidentel ou résulter de l’apparition de symptômes non spécifiques tels que des douleurs abdominales, une masse abdominale ou un saignement gastro-intestinal. Une rupture dans la cavité péritonéale avec péritonite représente un événement très rare, et la littérature fait état de très peu de cas de péritonite généralisée comme présentation clinique initiale de GIST. Nous rapportons, dans cet article, un cas inhabituel de GIST révélé par une péritonite généralisée provoquée par une rupture spontanée dans la cavité abdominale. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasia of the gastrointestinal tract. The gastric presentation is the most frequent (60–70%) followed by the small intestine presentation (20–30%). GISTs have typical immunohistochemical features which are essential for diagnosis. About 95% of GISTs are positive for c-KIT expression (CD117 antigen), a transmembrane tyrosine kinase receptor which activation leads to cell proliferation. Surgery is the treatment of choice for resectable tumours, whereas for unresectable tumours the standard treatment is the administration of imatinib (Glivec®), a c-KIT/PDGFRA competitive inhibitor. Response rate to imatinib treatment is about 80%. GIST diagnosis might be incidental or due to the appearance of aspecific symptoms such as abdominal pain, abdominal mass or gastrointestinal bleeding. Rupture in the peritoneal cavity with peritonitis represents a very rare event and very few cases of generalized peritonitis as initial presentation of GIST, are reported in the literature.We report here an unusual case of gastric GIST presenting with generalized peritonitis due to spontaneous rupture in the abdominal cavity.